A) Prolixin B) Geodon C) Risperdal D) Zyprexa
A) Abilify B) Invega C) Clozaril D) Zyprexa
A) Seroquel B) Zyprexa C) Invega D) Abilify
A) Risperdal B) Abilify C) Seroquel D) Zyprexa
A) Risperdal B) Abilify C) Seroquel D) Geodon
A) Clozapine B) Ziprasidone C) Quetiapine D) Olanzapine
A) Aripriprazole B) Risperidone C) Ziprasidone D) Paliperidone
A) Seroquel B) Risperdal C) Geodon D) Clozaril
A) Paliperidone B) Aripiprazole C) Clozapine D) Ziprasidone
A) Olazapine B) Risperdone C) Paliperidone D) Quetiapine
A) Aripiprazole and Paliperidone B) Clozapine and Risperadone C) Risperidone and Paliperidone D) Clozapine and Aripiprazole
A) 1-3 B) 2-5 C) 1 D) 4-5
A) 6 B) 24 C) 18 D) 12
A) FALSE B) TRUE
A) Develop more adaptive coping skills B) Foster patients' medication compliance C) Prevent relapse into another psychotic episode D) Minimize side effects of medication
A) several weeks after discontinuation of medication B) six months after discontinuation of medication C) directly after discontinuation of medication D) one year after discontinuation of medication
A) Symmetrel B) Thorazine C) Artane D) Clozaril
A) enhanced efficacy in treatment-resistant patients B) tardive dyskinesia more common C) weight gain more common D) increased effectiveness for positive, negative, and disorganized symptoms
A) Haloperiodol B) Clozapine C) Prochlorperazine D) Risperidone
A) Anxiolitics B) Alcohol C) Anticonvulsants D) Stimulants
A) Alcohol B) Merperidine C) Halperiodol D) Beta blockers
A) Beta blockers B) Anticonvulsants C) Antacids D) Nicotine
A) Beta blockers B) SSRIs C) Tricyclic antidepressants D) Alcohol
A) FALSE B) TRUE
A) Drug holidays B) Alcohol use C) Tobacco use D) Male gender
A) FALSE B) TRUE
A) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia. B) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia. C) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia. D) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications.
A) Acute dystonia B) Ataxia C) Akinesia D) Akathesia
A) Gynecomastia B) Agranulocytosis C) Neuroleptic Malignant Syndrome D) Postural hypotension
A) FALSE B) TRUE
A) FALSE B) TRUE
A) antagonize the normal dopamine-mediated inhibition of prolactin release. B) block D2 receptors in the pituitary gland and inhibit prolactin secretion. C) agonize the normal dopamine-mediated inhibition of prolactin release. D) block D2 receptors in the pituitary gland and decrease prolactin secretion.
A) hungry hungry hippos B) neuroendocrine changes C) molecular structure D) receptor binding and DA turnover
A) Butyrophenones B) Phenothiazines C) Thioxanthenenes D) Sleepykoaladones
A) Potent; low; higher B) Potent; low; lower C) Weak; high; higher D) Weak; high; lower
A) Anhedonia B) Formal thought disorder C) Delusions D) Hallucinations
A) Neurological disorders B) Endocrine disorders C) Metabolic disorders D) All of the above E) Autoimmune diseases
A) Stimulants B) Opioids C) Hallucinogens D) All of the above E) Alcohol
A) FALSE B) TRUE
A) negative symptoms of Schizophrenia. B) All of the above. C) positive symptoms of Schizophrenia. D) disorganized symptoms of Schizophrenia.
A) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release. B) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake. C) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release. D) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake.
A) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. B) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. C) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. D) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine.
A) increased rates of synthesis B) increased tap dancing C) increased rates of firing D) increased release of dopamine
A) piperideines B) aliphatics C) thioxanthenes D) piperazines
A) menstrual irregularity B) all of the above C) galactorrhea D) genecomastia
A) Benadryl (diphenhydramine) B) Symmetrel (amantadine) C) Artane (trihexphenidyl) D) Cogentin (benztropine) E) Inapsine (droperiodol)
A) TRUE B) FALSE
A) polypharmacy B) superior impact on positive symptoms C) comparative lack of EPS D) actual impact at the biological level
A) Haldol B) Abilify C) Invega D) Clozaril
A) Clorazil B) Geodon C) Risperdal D) Seroquel |